Explore the full directors' dealings record of TETRALOGIC PHARMACEUTICALS CORP, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €990. The latest transaction was disclosed on 10 February 2016 (Cession). Among the most active insiders: Clarus Lifesciences II, L.P.. All data is accessible without an account.
11
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
11 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.